Funding · Company
Kate Therapeutics Inc.
San Diego, CABiotech & Pharma
Kate Therapeutics Inc. of San Diego, CA has disclosed $57M across 2 Form D offerings filed with the SEC between Aug 7, 2024 and Aug 7, 2024.
$57M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$22M
Form D · Aug 7, 2024 ↗
Q3 2024
· target $23M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002032702Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →